Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Protein Design Labs, Merck KGaA deal

Merck acquired a non-exclusive worldwide license to PDLI's antibody

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE